CLPT

$9.03-0.15 (-1.63%)

Market ClosedAs of Mar 20, 8:00 PM UTC

ClearPoint Neuro, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$9.03
Potential Upside
5%
Whystock Fair Value$9.48
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventi...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$268.63M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.07
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-145.77%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
5.56

Recent News

MarketBeat
Mar 18, 2026

ClearPoint Neuro Q4 Earnings Call Highlights

ClearPoint Neuro (NASDAQ:CLPT) reported higher revenue for both the fourth quarter and full year 2025 and outlined a two-phase growth strategy that management said is designed to expand the company’s presence across multiple neurosurgical markets while positioning for longer-term opportunities in ce

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 18, 2026

ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary

Moby summary of ClearPoint Neuro, Inc.'s Q4 2025 earnings call

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Motley Fool
Mar 17, 2026

ClearPoint Neuro (CLPT) Earnings Call Transcript

Joseph Burnett: Thank you. This is one of the largest unmet needs in all of medicine, and we at ClearPoint Neuro, Inc. believe we can play a crucial role in this exciting future. This foundation is made up of four growing product categories, a vetted pipeline of new development programs, an expanded manufacturing footprint, a thoroughly audited quality system, a collection of global regulatory approvals, an expansive IP portfolio, an installed base of more than 150 global centers, and the cash position and investor base to execute on our strategy.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates

ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -22.73% and +7.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 16, 2026

ClearPoint Neuro Inc (CLPT) Q4 2025 Earnings Report Preview: What To Expect

The consensus estimate for Q4 2025 revenue is $10.05 million, and the earnings are expected to come in at -$0.20 per share. The full year 2025's revenue is expected to be $36.60 million, and the earnings are expected to be -$0.83 per share. More detailed estimate data can be found on the Forecast page.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.